5-Benzyloxytryptamine as an antagonist of TRPM8

Bioorganic & Medicinal Chemistry Letters
2010.0

Abstract

5-Benzyloxytryptamine 19 was found to act as an antagonist of the TRPM8 ion-channel. For example, 19 had an IC(50) of 0.34 μM when menthol was used as the stimulating agonist. Related commercially-available tryptamine derivatives showed diminished, or no antagonist activity at TRPM8. The structural similarity of 5-benzyloxytryptamine to other literature TRPM8 antagonists was noted.

Knowledge Graph

Similar Paper

5-Benzyloxytryptamine as an antagonist of TRPM8
Bioorganic & Medicinal Chemistry Letters 2010.0
Identification of a Potent Tryptophan-Based TRPM8 Antagonist With in Vivo Analgesic Activity
Journal of Medicinal Chemistry 2018.0
Identification of Indole Alkaloid Structural Units Important for Stimulus-Selective TRPM8 Inhibition: SAR Study of Naturally Occurring Iboga Derivatives
Journal of Natural Products 2014.0
Activation and Inhibition of Thermosensitive TRP Channels by Voacangine, an Alkaloid Present in Voacanga africana, an African Tree
Journal of Natural Products 2014.0
Activation and Inhibition of Thermosensitive TRP Channels by Voacangine, an Alkaloid Present in <i>Voacanga africana,</i> an African Tree
Journal of Natural Products 2014.0
Tetrahydroisoquinoline-Derived Urea and 2,5-Diketopiperazine Derivatives as Selective Antagonists of the Transient Receptor Potential Melastatin 8 (TRPM8) Channel Receptor and Antiprostate Cancer Agents
Journal of Medicinal Chemistry 2016.0
Synthesis and pharmacological evaluation of novel N-aryl-3,4-dihydro-1′H-spiro[chromene-2,4′-piperidine]-1′-carboxamides as TRPM8 antagonists
Bioorganic &amp; Medicinal Chemistry 2013.0
Transient Receptor Potential Melastatin 8 Channel (TRPM8) Modulation: Cool Entryway for Treating Pain and Cancer
Journal of Medicinal Chemistry 2016.0
N-Methyl-5-tert-butyltryptamine:  A Novel, Highly Potent 5-HT<sub>1D</sub> Receptor Agonist
Journal of Medicinal Chemistry 1999.0
Structure–Activity Relationship of Adenosine 5′-diphosphoribose at the Transient Receptor Potential Melastatin 2 (TRPM2) Channel: Rational Design of Antagonists
Journal of Medicinal Chemistry 2013.0